No improvement in mortality rates for COVID-19 patients treated with remdesivir

There are “no statistically significant differences” for mortality and serious adverse events in COVID-19 patients treated with remdesivir, a rapid evidence review carried out by the National Institute for Health and Care Excellence has concluded.…